All In Biotech

Drug Trial Radar · NCT00639158

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia

Last checked: Nov 20, 2026Latest source record: Jun 13, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 543 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

543

Actual

Start

Feb 2008

Primary completion

Oct 2008

Sponsor

Lead sponsor
AbbottIndustry
Sponsor type
Industry
First posted
Mar 20, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to compare the safety and efficacy of ABT-335 (investigational drug) coadministered with atorvastatin and ezetimibe to atorvastatin coadministered with ezetimibe in subjects with abnormal lipid (fat) levels in the blood.

Conditions

  • Dyslipidemias
  • Coronary Heart Disease
  • Combined (Atherogenic) Dyslipidemia
  • Mixed Dyslipidemia

Interventions

  • ABT-335Drug

    135 mg capsule, daily, 12 weeks

  • placeboDrug

    placebo capsule, daily, 12 weeks

  • atorvastatinDrug

    40 mg, tablet, daily, 12 weeks

  • ezetimibeDrug

    10 mg capsule, daily, 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Median Percent Change in Triglycerides From Baseline to Final VisitTime frame: Baseline to 12 Weeks (Final Visit)
  2. Mean Percent Change in High-Density Lipoprotein Cholesterol (HDL-C) From Baseline to Final VisitTime frame: Baseline to 12 weeks (Final Visit)

Locations

118 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Birmingham, Alabama

  • Site not named

    Columbiana, Alabama

  • Site not named

    Hueytown, Alabama

  • Site not named

    Ozark, Alabama

  • Site not named

    Tuscaloosa, Alabama

  • Site not named

    Sierra Vista, Arizona

  • Site not named

    Hot Springs, Arkansas

  • Site not named

    Carmichael, California

  • Site not named

    Concord, California

  • Site not named

    Long Beach, California

  • Site not named

    Long Beach, California

  • Site not named

    Los Angeles, California

  • Site not named

    Norwalk, California

  • Site not named

    Roseville, California

  • Site not named

    Sacramento, California

  • Site not named

    Santa Ana, California

  • Site not named

    Tustin, California

  • Site not named

    West Hills, California

  • Site not named

    Colorado Springs, Colorado

  • Site not named

    Denver, Colorado

  • Site not named

    Clearwater, Florida

  • Site not named

    Delray Beach, Florida

  • Site not named

    Fort Myers, Florida

  • Site not named

    Holly Hill, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Kissimmee, Florida

  • Site not named

    Longwood, Florida

  • Site not named

    Miami, Florida

  • Site not named

    New Port Richey, Florida

  • Site not named

    New Smyrna Beach, Florida

  • Site not named

    Ocala, Florida

  • Site not named

    Ormond Beach, Florida

  • Site not named

    Pembroke Pines, Florida

  • Site not named

    Sarasota, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    Winter Haven, Florida

  • Site not named

    Atlanta, Georgia

  • Site not named

    Augusta, Georgia

  • Site not named

    Roswell, Georgia

Showing 40 of 118 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.